Cargando…
Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005–2006
INTRODUCTION: European treatment guidelines in persons with known coronary heart disease (CHD) focus on adherence to antiplatelet therapy, β-blockers, ACE/ARBs, and lipid-lowering agents, with goals for blood pressure (BP) of < 140/90 mm Hg and LDL cholesterol of < 3.0 mmol/l. Data on adherenc...
Autores principales: | Vulic, Dusko, Loncar, Sasa, Krneta, Milenko, Skrbic, Ranko, Lazarevic, Aleksandar, Lee, Brian T., Lopez, Victor A., Wong, Nathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281337/ https://www.ncbi.nlm.nih.gov/pubmed/22371744 http://dx.doi.org/10.5114/aoms.2010.13891 |
Ejemplares similares
-
The Characteristics of Benzodiazepine Prescribing in the Republic of Srpska, Bosnia and Herzegovina
por: Maksimović, Žana M., et al.
Publicado: (2022) -
Risk factor indicators in offspring of patients with premature coronary heart disease in Banja Luka region/Republic of Srpska/Bosnia and Herzegovina
por: Vulic, Dusko, et al.
Publicado: (2016) -
Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up
por: Kalinić, Dragan, et al.
Publicado: (2022) -
Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and Herzegovina
por: Kalinić, Dragan, et al.
Publicado: (2023) -
Behavioral and Metabolic Risk Factors for Noncommunicable Diseases among Population in the Republic of Srpska (Bosnia and Herzegovina)
por: Majić, Aleksandar, et al.
Publicado: (2023)